News

Under the brand name Preventa, Sensiotec will market and sell the medical device in the US and Canada under an exclusive worldwide license with its affiliate, Wireless 2000.

The Vitesse intracranial stent study for ischemic therapy (VISSIT) clinical trial is designed to include up to 250 patients who demonstrate ischemic symptoms attributable to stenosis of an

The acquisition of Ovation delivers on Lundbeck’s strategic goal to build a commercial infrastructure in the US. Following the transaction Lundbeck will have a diverse portfolio of marketed

Merck has reported positive data from new subgroup analyses of a Phase III study that compared the company’s integrase inhibitor Isentress to efavirenz, an antiretroviral prescribed for previously

During the third quarter the company increased product revenue by 19% while instituting programs, which are expected to reduce future cash operating expenses by about $2.6 million per

The scanner and associated software are used to detect and provide a quantitative measurement of HER2/neu, a protein that is measured in breast cancer patients in order to

According to Abbott, a key facet of CELL-DYN Emerald is its compact size – weighing just 9kg – as well as its intuitive software interface that allows for

Laurence Birch, president and CEO of NeoPharm, said: “The preliminary results from our Phase I trial, which has not yet concluded, have been encouraging. As a result, we

Dr Caspari’s initial primary responsibilities will include managing the development, FDA clinical trial and submission activities for AppyScore, the company’s diagnostic test for human appendicitis. Most recently, Dr